 |
 |
Sandra Norris wrote: > How do you like Comtan? And how does it compare? > I quit Tasmar a year ago, not because of the statistical risk which is very small, but because I don't like the idea of periodic testing which on one hand is rigorously demanded, but on the other hand is not completely trusted. Might reconsider if it's demonstrated that no restriction beyond pre-screening for HBV is needed (unlikely), or if a more convincing test is found (none seen as of yet). Waited some months for Comtan, not nearly as good as Tasmar for PD fluctuations and peripheral effects, but good enough to continue using. Cheers, Joe -- J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013